Correlation of Mesalamine Pharmacokinetics With Local Availability
Phase of Trial: Phase IV
Latest Information Update: 18 May 2017
Price : $35 *
At a glance
- Drugs Mesalazine (Primary)
- Indications Crohn's disease; Diverticulitis; Inflammatory bowel diseases; Ulcerative colitis; Ulcerative proctitis
- Focus Pharmacokinetics
- Sponsors University of Michigan
- 02 May 2017 Status changed from active, no longer recruiting to completed.
- 11 May 2016 Planned End Date changed from 1 Sep 2015 to 1 Apr 2017.
- 10 Dec 2013 New trial record